White House Weighs Temporarily Lifting COVID-19 Vaccine Patents

The Biden administration is considering temporarily suspending intellectual property protections for COVID-19 vaccines and treatments to allow other countries to replicate existing vaccines for their own populations, but the idea faces opposition from the pharmaceutical industry, the European Union and other developed countries. White House officials reportedly held a meeting with policy makers on March 22 about the possibility of waiving patents, which would apply to all medical technologies created in connection to COVID-19. Ahead of that meeting, CNBC reports,...
Article Type: 
Tags: 
Site Name: 
InsideHealthPolicy.com
FDA Issue: 
FDA Week - 04/02/2021
FDA Volume: 
Vol. 27, No. 13
Author: 


36 Democrats Urge Commerce To Kill Plan To Undermine March-In Rights

A group of 36 House and Senate Democrats are urging the Commerce Department to reverse an 11th-hour rule proposed by the Trump administration that would prohibit the government from using high prices as the sole reason to license third parties to make drugs developed with federal funding. Commerce’s National Institute of Standards and Technologies proposed that “march-in rights shall not be exercised by an agency exclusively on the basis of business decisions of a contractor regarding the pricing of commercial...
Article Type: 
Site Name: 
InsideHealthPolicy.com
IDP Issue: 
Inside Drug Pricing - 04/05/2021
IDP Volume: 
Vol. 4, No. 14
Author: 


Several State-Run Exchanges Extend Special Enrollment Deadlines

Editor's Note: This story was updated with new information from Washington's exchange. Several state-based exchange will extend their special enrollment periods through Aug. 15 or beyond to better align with the federal government’s decision to keep healthcare.gov open longer so consumers can access the increased Affordable Care Act tax credits available under the American Rescue Plan. Healthcare.gov has been open since Feb. 15 and the administration initially planned to close the enrollment window on May 15. But...
Article Type: 
Tags: 
Site Name: 
InsideHealthPolicy.com
CMS Issue: 
Inside CMS - 04/01/2021
CMS Volume: 
Vol. 24, No. 13
HEA Issue: 
Health Exchange Alert Weekly Report - 04/07/2021
HEA Volume: 
Vol. 9, No. 14
Author: 










Pages

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.